Advertisement

Mastectomy

  • David R. Brenin
  • David W. Kinne
Chapter
Part of the Current Clinical Oncology book series (CCO)

Abstract

The appropriate local management of breast cancer has been a subject of controversy since the inception of breast surgery. The failure of radical surgery to cure many patients with breast cancer has resulted in a close examination of surgical procedures used to treat the disease as well as intense investigation of the disease itself. Over time, a new paradigm evolved for the treatment of breast cancer. This new thinking revolves around the systemic nature of breast cancer at the time of diagnosis. Appropriately, the procedures utilized by surgeons in the treatment of breast cancer have evolved in parallel with these changing concepts. From the mid-1990s onward, most patients with early invasive breast cancer or ductal carcinoma in situ have been treated with breast-conserving therapy (BCT) (1,2). This change has come about slowly and was caused not only by the results of randomized trials but also by changes in our perception of the biology of breast cancer, the detection of smaller tumors, an increased understanding of radiotherapy, more use of systemic therapy, and the recognition of the importance of patient involvement in decision making. Mastectomy may no longer be considered the gold standard, but it still represents an important modality in the modern treatment of breast cancer patients.

Keywords

Breast Reconstruction Axillary Dissection Radical Mastectomy Pectoralis Major Muscle Total Mastectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP (1998) The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 83, 1262–1273.PubMedCrossRefGoogle Scholar
  2. 2.
    Winchester DJ, Menck HR, Winchester DP (1997) National treatment trends for ductal carcinoma in situ of the breast. Arch. Surg. 132, 660–665.PubMedCrossRefGoogle Scholar
  3. 3.
    Degenshein GA, Ceccarelli F (1977) The history of breast cancer surgery. Part 1. Early beginning to Halsted. Breast 3, 28–35.Google Scholar
  4. 4.
    Halsted WS (1894) The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann. Surg. 20, 497–555.PubMedCrossRefGoogle Scholar
  5. 5.
    Bland K, Copeland III, E (1998) Halsted radical mastectomy. In Bland K, Copeland E III (eds.) The Breast. WB Saunders, Philadelphia, pp. 856.Google Scholar
  6. 6.
    Clarke D, Martinez A, Cox RS (1983) Analysis of cosmetic results and complications in patients with stage I and II breast cancer treated by biopsy and irradiation. Int. J. Radiat. Oncol. Biol. Phys. 9, 1807–1813.PubMedCrossRefGoogle Scholar
  7. 7.
    Harris JR, Levene MB, Svensson G, Hellman S (1979) Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int. J. Radiat. Oncol. Biol. Phys. 5, 257–261.PubMedCrossRefGoogle Scholar
  8. 8.
    Ross JG, Hussey DH, Mayr NA, Davis CS (1993) Acute and late reactions to radiation therapy in patients with collagen vascular diseases. Cancer 71, 3744–3752.PubMedCrossRefGoogle Scholar
  9. 9.
    Robertson JM, Clarke DH, Pevzner MM, Matter RC (1991) Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease. Cancer 68, 502–508.PubMedCrossRefGoogle Scholar
  10. 10.
    Fleck R, McNeese MD, Ellerbroek NA, Hunter TA, Holmes FA (1989) Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. Int. J. Radiat. Oncol. Biol. Phys. 17, 829–833.PubMedCrossRefGoogle Scholar
  11. 11.
    Brenin, DR, Morrow, M (1998) Is mastectomy over-treatment for ductal carcinoma in situ? Breast Cancer Res. Treat. 50, 250.Google Scholar
  12. 12.
    Taneja C, Gardner B (1998) Therapeutic value of axillary lymph node dissection for breast cancer. In Bland K, Copeland E III (eds.), The Breast. WB Saunders, Philadelphia, pp. 943–961.Google Scholar
  13. 13.
    Turner-Warwick R (1958) The lymphatics of the breast. Br. J. Surg. 46, 574–582.CrossRefGoogle Scholar
  14. 14.
    Patey DH, Dyson WH (1948) The prognosis of carcinoma of the breast in relation to the type of operation performed. Br. J. Cancer 2, 7–13.PubMedCrossRefGoogle Scholar
  15. 15.
    Patey DH (1967) A review of 146 cases of carcinoma of the breast operated on between 1930 and 1943. Br. J. Cancer 21, 260–269.PubMedCrossRefGoogle Scholar
  16. 16.
    Auchincloss H (1963) Significance of location and number of axillary metastases in carcinoma of the breast. Ann. Surg. 158, 37–46.PubMedCrossRefGoogle Scholar
  17. 17.
    Auchincloss H (1970) Modified radical mastectomy: why not Am. J. Surg. 119, 506–509.PubMedCrossRefGoogle Scholar
  18. 18.
    Madden JL (1965) Modified radical mastectomy. Surg. Gynecol. Obstet. 121, 1221–1230.PubMedGoogle Scholar
  19. 19.
    Ivens D, Hoe AL, Podd TJ, et al. (1992) Assessment of morbidity from complete axillary dissection. Br. J. Cancer 66, 136–138.PubMedCrossRefGoogle Scholar
  20. 20.
    Kiel KD, Rademacker AW (1996) Early-stage breast cancer: arm edema after wide excision and breast irradiation. Radiology 198, 279–283.PubMedGoogle Scholar
  21. 21.
    Liljegren G, Holmberg L (1997) Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomized trial. Eur. J. Cancer 33, 193–199.PubMedCrossRefGoogle Scholar
  22. 22.
    Rosen PP, Lesser ML, Kinne DW, et al. (1983) Discontinuous or “skip” metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann. Surg. 197, 276–283.PubMedCrossRefGoogle Scholar
  23. 23.
    Boova RS, Bonanni R, Rosato FE (1982) Patterns of axillary nodal involvement in breast cancer, predictability of level one dissection. Ann. Surg. 196, 642–644.PubMedCrossRefGoogle Scholar
  24. 24.
    Veronesi U, Rilke F, Luini A, et al. (1987) Distribution of axillary node metastases by level of invasion. Cancer 59, 682–687.PubMedCrossRefGoogle Scholar
  25. 25.
    Brenin, DR, Morrow, M (1998) Conventional axillary dissection: extent, local control, and morbidity. Semin. Breast Dis. 1, 118–124.Google Scholar
  26. 26.
    Halsted WS (1907) The results of radical operations for the cure of cancer of the breast. Trans. Am. Surg. Assoc. 25, 61–79.Google Scholar
  27. 27.
    Carlson GW, Bostwick J 3rd, Styblo TM, et al. (1997) Skin-sparing mastectomy. Oncologie and reconstructive considerations. Ann. Surg. 225, 570–578.PubMedCrossRefGoogle Scholar
  28. 28.
    Kroll SS, Schusterman MA, Tadjalli HE, Singletary SE, Ames FC (1997) Risk of recurrence after treatment of early breast cancer with skin-sparing mastectomy. Ann. Surg. Oncol. 4, 193–197.PubMedCrossRefGoogle Scholar
  29. 29.
    Newman LA, Kuerer HM, Hunt KK (1998) Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann. Surg. Oncol. 5, 620–626.PubMedCrossRefGoogle Scholar
  30. 30.
    Harris JR, Morrow M (1996) Treatment of early-stage breast cancer. In Harris JR, Lippman ME, Morrow M, Hellman S (eds.), Diseases of the Breast. Lippincott-Raven, Philadelphia, pp. 529.Google Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • David R. Brenin
  • David W. Kinne

There are no affiliations available

Personalised recommendations